339 related articles for article (PubMed ID: 19719390)
1. Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004.
Markowitz LE; Sternberg M; Dunne EF; McQuillan G; Unger ER
J Infect Dis; 2009 Oct; 200(7):1059-67. PubMed ID: 19719390
[TBL] [Abstract][Full Text] [Related]
2. Seroepidemiology of human papillomavirus type 11 in the United States: results from the third National Health And Nutrition Examination Survey, 1991--1994.
Hariri S; Dunne EF; Sternberg M; Unger ER; Meadows KS; Karem KL; Markowitz LE
Sex Transm Dis; 2008 Mar; 35(3):298-303. PubMed ID: 18091027
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of human papillomavirus type 16 infection in the United States.
Stone KM; Karem KL; Sternberg MR; McQuillan GM; Poon AD; Unger ER; Reeves WC
J Infect Dis; 2002 Nov; 186(10):1396-402. PubMed ID: 12404154
[TBL] [Abstract][Full Text] [Related]
4. HPV 6/11, 16, 18 seroprevalence in men in two US cities.
Dunne EF; Nielson CM; Hagensee ME; Papenfuss MR; Harris RB; Herrel N; Gourlie J; Abrahamsen M; Markowitz LE; Giuliano AR
Sex Transm Dis; 2009 Nov; 36(11):671-4. PubMed ID: 19809385
[TBL] [Abstract][Full Text] [Related]
5. Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States.
Thompson DL; Douglas JM; Foster M; Hagensee ME; Diguiseppi C; Barón AE; Cameron JE; Spencer TC; Zenilman J; Malotte CK; Bolan G; Kamb ML; Peterman TA;
J Infect Dis; 2004 Nov; 190(9):1563-74. PubMed ID: 15478060
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus (HPV) 6, 11, 16, and 18 prevalence among females in the United States--National Health And Nutrition Examination Survey, 2003-2006: opportunity to measure HPV vaccine impact?
Dunne EF; Sternberg M; Markowitz LE; McQuillan G; Swan D; Patel S; Unger ER
J Infect Dis; 2011 Aug; 204(4):562-5. PubMed ID: 21791658
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and incidence of HPV genital infection in women.
Velicer C; Zhu X; Vuocolo S; Liaw KL; Saah A
Sex Transm Dis; 2009 Nov; 36(11):696-703. PubMed ID: 19652630
[TBL] [Abstract][Full Text] [Related]
8. Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia.
Newall AT; Brotherton JM; Quinn HE; McIntyre PB; Backhouse J; Gilbert L; Esser MT; Erick J; Bryan J; Formica N; MacIntyre CR
Clin Infect Dis; 2008 Jun; 46(11):1647-55. PubMed ID: 18444790
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence and genital DNA prevalence of HPV types 6, 11, 16 and 18 in a cohort of young Norwegian women: study design and cohort characteristics.
Skjeldestad FE; Mehta V; Sings HL; Øvreness T; Turpin J; Su L; Boerckel P; Roberts C; Bryan J; Jansen KU; Esser MT; Liaw KL
Acta Obstet Gynecol Scand; 2008; 87(1):81-8. PubMed ID: 17943470
[TBL] [Abstract][Full Text] [Related]
10. Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine.
Giuliano AR; Lazcano-Ponce E; Villa L; Nolan T; Marchant C; Radley D; Golm G; McCarroll K; Yu J; Esser MT; Vuocolo SC; Barr E
J Infect Dis; 2007 Oct; 196(8):1153-62. PubMed ID: 17955433
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007.
Jain N; Euler GL; Shefer A; Lu P; Yankey D; Markowitz L
Prev Med; 2009 May; 48(5):426-31. PubMed ID: 19100762
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of human papillomavirus type 16 in children.
Dunne EF; Karem KL; Sternberg MR; Stone KM; Unger ER; Reeves WC; Markowitz LE
J Infect Dis; 2005 Jun; 191(11):1817-9. PubMed ID: 15871113
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of human papillomavirus antibodies in males and females in England.
Desai S; Chapman R; Jit M; Nichols T; Borrow R; Wilding M; Linford C; Lowndes CM; Nardone A; Pebody R; Soldan K
Sex Transm Dis; 2011 Jul; 38(7):622-9. PubMed ID: 21317688
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006.
Hariri S; Unger ER; Sternberg M; Dunne EF; Swan D; Patel S; Markowitz LE
J Infect Dis; 2011 Aug; 204(4):566-73. PubMed ID: 21791659
[TBL] [Abstract][Full Text] [Related]
15. Sociodemographic factors associated with high-risk human papillomavirus infection.
Kahn JA; Lan D; Kahn RS
Obstet Gynecol; 2007 Jul; 110(1):87-95. PubMed ID: 17601901
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of human papillomavirus types 16 and 18 in the general population in Taiwan: implication for optimal age of human papillomavirus vaccination.
Chen CJ; Viscidi RP; Chuang CH; Huang YC; Chiu CH; Lin TY
J Clin Virol; 2007 Feb; 38(2):126-30. PubMed ID: 17210269
[TBL] [Abstract][Full Text] [Related]
17. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years.
Brown DR; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Koutsky LA; Tay EH; Garcia P; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Joura EA; Kurman RJ; Majewski S; Muñoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan J; Lupinacci LC; Giacoletti KE; Sings HL; James M; Hesley TM; Barr E
J Infect Dis; 2009 Apr; 199(7):926-35. PubMed ID: 19236279
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of 9 Human Papillomavirus Types in the United States, 2005-2006.
Liu G; Markowitz LE; Hariri S; Panicker G; Unger ER
J Infect Dis; 2016 Jan; 213(2):191-8. PubMed ID: 26320259
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected and uninfected women from Brazil.
Nicol AF; Grinsztejn B; Friedman RK; Veloso VG; Cunha CB; Georg I; Pilotto JH; Moreira RI; Castro CA; Silver B; Viscidi RP
J Clin Virol; 2013 Jun; 57(2):147-51. PubMed ID: 23490398
[TBL] [Abstract][Full Text] [Related]
20. Baseline demographic characteristics of subjects enrolled in international quadrivalent HPV (types 6/11/16/18) vaccine clinical trials.
Paavonen J;
Curr Med Res Opin; 2008 Jun; 24(6):1623-34. PubMed ID: 18435868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]